Global mRNA Capping Enzyme Market Research Report 2024

Publication ID:

PB505242005

Publication Date:

May 31, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global mRNA Capping Enzyme market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for mRNA Capping Enzyme is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for mRNA Capping Enzyme is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for mRNA Capping Enzyme in Biopharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of mRNA Capping Enzyme include NEB, TriLink Bio Technologies, Aldevron, Qiagen N.V., Promega, Takara Bio Inc., Novoprotein, Vazyme and Hongene Biotech Corporatio, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for mRNA Capping Enzyme, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Capping Enzyme.
Report Scope
The mRNA Capping Enzyme market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global mRNA Capping Enzyme market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Capping Enzyme companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
NEB
TriLink Bio Technologies
Aldevron
Qiagen N.V.
Promega
Takara Bio Inc.
Novoprotein
Vazyme
Hongene Biotech Corporatio
Segment by Type
Vaccinia Capping Enzyme
2'-O-Methyltransferase
Segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Capping Enzyme companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Capping Enzyme Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Vaccinia Capping Enzyme
1.2.3 2'-O-Methyltransferase
1.3 Market by Application
1.3.1 Global mRNA Capping Enzyme Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Capping Enzyme Market Perspective (2019-2030)
2.2 mRNA Capping Enzyme Growth Trends by Region
2.2.1 Global mRNA Capping Enzyme Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 mRNA Capping Enzyme Historic Market Size by Region (2019-2024)
2.2.3 mRNA Capping Enzyme Forecasted Market Size by Region (2025-2030)
2.3 mRNA Capping Enzyme Market Dynamics
2.3.1 mRNA Capping Enzyme Industry Trends
2.3.2 mRNA Capping Enzyme Market Drivers
2.3.3 mRNA Capping Enzyme Market Challenges
2.3.4 mRNA Capping Enzyme Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Capping Enzyme Players by Revenue
3.1.1 Global Top mRNA Capping Enzyme Players by Revenue (2019-2024)
3.1.2 Global mRNA Capping Enzyme Revenue Market Share by Players (2019-2024)
3.2 Global mRNA Capping Enzyme Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by mRNA Capping Enzyme Revenue
3.4 Global mRNA Capping Enzyme Market Concentration Ratio
3.4.1 Global mRNA Capping Enzyme Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Capping Enzyme Revenue in 2023
3.5 mRNA Capping Enzyme Key Players Head office and Area Served
3.6 Key Players mRNA Capping Enzyme Product Solution and Service
3.7 Date of Enter into mRNA Capping Enzyme Market
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Capping Enzyme Breakdown Data by Type
4.1 Global mRNA Capping Enzyme Historic Market Size by Type (2019-2024)
4.2 Global mRNA Capping Enzyme Forecasted Market Size by Type (2025-2030)
5 mRNA Capping Enzyme Breakdown Data by Application
5.1 Global mRNA Capping Enzyme Historic Market Size by Application (2019-2024)
5.2 Global mRNA Capping Enzyme Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America mRNA Capping Enzyme Market Size (2019-2030)
6.2 North America mRNA Capping Enzyme Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America mRNA Capping Enzyme Market Size by Country (2019-2024)
6.4 North America mRNA Capping Enzyme Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe mRNA Capping Enzyme Market Size (2019-2030)
7.2 Europe mRNA Capping Enzyme Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe mRNA Capping Enzyme Market Size by Country (2019-2024)
7.4 Europe mRNA Capping Enzyme Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific mRNA Capping Enzyme Market Size (2019-2030)
8.2 Asia-Pacific mRNA Capping Enzyme Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific mRNA Capping Enzyme Market Size by Region (2019-2024)
8.4 Asia-Pacific mRNA Capping Enzyme Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America mRNA Capping Enzyme Market Size (2019-2030)
9.2 Latin America mRNA Capping Enzyme Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America mRNA Capping Enzyme Market Size by Country (2019-2024)
9.4 Latin America mRNA Capping Enzyme Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Capping Enzyme Market Size (2019-2030)
10.2 Middle East & Africa mRNA Capping Enzyme Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa mRNA Capping Enzyme Market Size by Country (2019-2024)
10.4 Middle East & Africa mRNA Capping Enzyme Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NEB
11.1.1 NEB Company Detail
11.1.2 NEB Business Overview
11.1.3 NEB mRNA Capping Enzyme Introduction
11.1.4 NEB Revenue in mRNA Capping Enzyme Business (2019-2024)
11.1.5 NEB Recent Development
11.2 TriLink Bio Technologies
11.2.1 TriLink Bio Technologies Company Detail
11.2.2 TriLink Bio Technologies Business Overview
11.2.3 TriLink Bio Technologies mRNA Capping Enzyme Introduction
11.2.4 TriLink Bio Technologies Revenue in mRNA Capping Enzyme Business (2019-2024)
11.2.5 TriLink Bio Technologies Recent Development
11.3 Aldevron
11.3.1 Aldevron Company Detail
11.3.2 Aldevron Business Overview
11.3.3 Aldevron mRNA Capping Enzyme Introduction
11.3.4 Aldevron Revenue in mRNA Capping Enzyme Business (2019-2024)
11.3.5 Aldevron Recent Development
11.4 Qiagen N.V.
11.4.1 Qiagen N.V. Company Detail
11.4.2 Qiagen N.V. Business Overview
11.4.3 Qiagen N.V. mRNA Capping Enzyme Introduction
11.4.4 Qiagen N.V. Revenue in mRNA Capping Enzyme Business (2019-2024)
11.4.5 Qiagen N.V. Recent Development
11.5 Promega
11.5.1 Promega Company Detail
11.5.2 Promega Business Overview
11.5.3 Promega mRNA Capping Enzyme Introduction
11.5.4 Promega Revenue in mRNA Capping Enzyme Business (2019-2024)
11.5.5 Promega Recent Development
11.6 Takara Bio Inc.
11.6.1 Takara Bio Inc. Company Detail
11.6.2 Takara Bio Inc. Business Overview
11.6.3 Takara Bio Inc. mRNA Capping Enzyme Introduction
11.6.4 Takara Bio Inc. Revenue in mRNA Capping Enzyme Business (2019-2024)
11.6.5 Takara Bio Inc. Recent Development
11.7 Novoprotein
11.7.1 Novoprotein Company Detail
11.7.2 Novoprotein Business Overview
11.7.3 Novoprotein mRNA Capping Enzyme Introduction
11.7.4 Novoprotein Revenue in mRNA Capping Enzyme Business (2019-2024)
11.7.5 Novoprotein Recent Development
11.8 Vazyme
11.8.1 Vazyme Company Detail
11.8.2 Vazyme Business Overview
11.8.3 Vazyme mRNA Capping Enzyme Introduction
11.8.4 Vazyme Revenue in mRNA Capping Enzyme Business (2019-2024)
11.8.5 Vazyme Recent Development
11.9 Hongene Biotech Corporatio
11.9.1 Hongene Biotech Corporatio Company Detail
11.9.2 Hongene Biotech Corporatio Business Overview
11.9.3 Hongene Biotech Corporatio mRNA Capping Enzyme Introduction
11.9.4 Hongene Biotech Corporatio Revenue in mRNA Capping Enzyme Business (2019-2024)
11.9.5 Hongene Biotech Corporatio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

NEB
TriLink Bio Technologies
Aldevron
Qiagen N.V.
Promega
Takara Bio Inc.
Novoprotein
Vazyme
Hongene Biotech Corporatio

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂